Medication monograph

ruxolitinib

JAK InhibitorsAntineoplasticsImmunomodulating AgentsJanus Kinase InhibitorKinase Inhibitor

Clinical reference

Product monograph

OPZELURA- ruxolitinib cream

JAKAFI- ruxolitinib tablet

Brands & formulations

JAKAVI

Marketed

5 MGORALTABLET[ "ruxolitinib (ruxolitinib phosphate)" ]

JAKAVI

Marketed

15 MGORALTABLET[ "ruxolitinib (ruxolitinib phosphate)" ]

JAKAVI

Marketed

20 MGORALTABLET[ "ruxolitinib (ruxolitinib phosphate)" ]

JAKAVI

Marketed

10 MGORALTABLET[ "ruxolitinib (ruxolitinib phosphate)" ]

OPZELURA

Marketed

1.5 %TOPICALCREAM[ "ruxolitinib (ruxolitinib phosphate)" ]

Pricing

Jakavi

Novartis · 5 mg

56: $9789.99

Jakavi

Novartis · 10 mg

56: $9861.41

Jakavi

Novartis · 15 mg

56: $9932.84

Jakavi

Novartis · 20 mg

56: $10075.7

Classification